Kurt Eger

1.2k total citations
76 papers, 1.0k citations indexed

About

Kurt Eger is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Kurt Eger has authored 76 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Organic Chemistry, 32 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Kurt Eger's work include Synthesis and Biological Evaluation (17 papers), Synthesis and Reactivity of Heterocycles (14 papers) and Synthesis and Reactions of Organic Compounds (9 papers). Kurt Eger is often cited by papers focused on Synthesis and Biological Evaluation (17 papers), Synthesis and Reactivity of Heterocycles (14 papers) and Synthesis and Reactions of Organic Compounds (9 papers). Kurt Eger collaborates with scholars based in Germany, United States and Switzerland. Kurt Eger's co-authors include Michael Gütschow, H. J. Roth, Sunna Hauschildt, Hermann J. Roth, Sylvia S. W. Ng, William D. Figg, Christa E. Müller, Ulf Neumann, Michael Weiß and Frederick A. Luzzio and has published in prestigious journals such as Clinical Cancer Research, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Kurt Eger

71 papers receiving 979 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt Eger Germany 18 532 428 105 93 84 76 1.0k
Kunitomo Adachi Japan 16 420 0.8× 936 2.2× 79 0.8× 47 0.5× 65 0.8× 27 1.2k
Masafumi Arita Japan 9 396 0.7× 762 1.8× 66 0.6× 35 0.4× 37 0.4× 13 944
Giulia Menozzi Italy 21 1.1k 2.2× 406 0.9× 41 0.4× 49 0.5× 94 1.1× 91 1.4k
Laurent Schio France 15 486 0.9× 344 0.8× 39 0.4× 78 0.8× 76 0.9× 29 1.0k
John J. Parlow United States 24 910 1.7× 755 1.8× 194 1.8× 38 0.4× 40 0.5× 45 1.4k
Francesco Bondavalli Italy 27 1.6k 3.0× 581 1.4× 85 0.8× 46 0.5× 160 1.9× 104 2.0k
Angelo Ranise Italy 27 1.5k 2.9× 555 1.3× 56 0.5× 43 0.5× 140 1.7× 108 2.0k
William C. Ripka United States 21 403 0.8× 722 1.7× 114 1.1× 18 0.2× 204 2.4× 38 1.1k
Steven E. Hall United States 20 574 1.1× 952 2.2× 49 0.5× 19 0.2× 126 1.5× 40 1.5k
Mark E. Schnute United States 19 715 1.3× 618 1.4× 32 0.3× 34 0.4× 134 1.6× 25 1.4k

Countries citing papers authored by Kurt Eger

Since Specialization
Citations

This map shows the geographic impact of Kurt Eger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Eger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Eger more than expected).

Fields of papers citing papers by Kurt Eger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Eger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Eger. The network helps show where Kurt Eger may publish in the future.

Co-authorship network of co-authors of Kurt Eger

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Eger. A scholar is included among the top collaborators of Kurt Eger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Eger. Kurt Eger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gebhardt, Rolf, Robert Günther, Sebastian Zellmer, et al.. (2009). 4‐Aminoethylamino‐emodin – a novel potent inhibitor of GSK‐3β– acts as an insulin‐sensitizer avoiding downstream effects of activated β‐catenin. Journal of Cellular and Molecular Medicine. 14(6a). 1276–1293. 12 indexed citations
2.
3.
Gebhardt, Rolf, et al.. (2004). Synthesis and biological evaluation of new derivatives of emodin. Bioorganic & Medicinal Chemistry. 12(22). 5961–5971. 42 indexed citations
4.
Shaheen, Mohammed, et al.. (2003). Structure activity analysis of the pro-apoptotic, antitumor effect of nitrostyrene adducts and related compounds. Biochemical Pharmacology. 65(4). 603–610. 67 indexed citations
5.
Thiele, Andrea, Renate Bang, Michael Gütschow, et al.. (2002). Cytokine modulation and suppression of liver injury by a novel analogue of thalidomide. European Journal of Pharmacology. 453(2-3). 325–334. 13 indexed citations
6.
Gütschow, Michael, et al.. (2001). Aza analogues of thalidomide. Bioorganic & Medicinal Chemistry. 9(4). 1059–1065. 32 indexed citations
7.
Hess, Sonja, et al.. (2001). Rapid and sensitive LC separation of new impurities in trimethoprim. Journal of Pharmaceutical and Biomedical Analysis. 25(3-4). 531–538. 7 indexed citations
8.
9.
Krautheim, Andrea, et al.. (2000). Michael adducts of ascorbic acid as inhibitors of protein phosphatase 2A and inducers of apoptosis. Bioorganic & Medicinal Chemistry Letters. 10(14). 1605–1608. 17 indexed citations
10.
Schultz, Joachim E., et al.. (2000). Inhibition of protein phosphatases by Michael adducts of ascorbic acid analogues with α,β-unsaturated carbonyl compounds. Bioorganic & Medicinal Chemistry. 8(4). 807–813. 5 indexed citations
11.
Zwingenberger, K., et al.. (1998). 5′-Substituted Thalidomide Analogs as Modulators of TNF-α. Archiv der Pharmazie. 331(1). 7–12. 19 indexed citations
12.
Beck, Rainer, et al.. (1996). Ligands for the affinity chromatography of mammalian thymidine kinase 1: Strategy, synthesis and evaluation. Pharmaceutica Acta Helvetiae. 71(4). 279–291. 6 indexed citations
13.
Munch‐Petersen, Birgitte, et al.. (1995). Different affinity of the two forms of human cytosolic thymidine kinase towards pyrimidine analogs. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1250(2). 158–162. 13 indexed citations
14.
15.
Eger, Kurt, et al.. (1992). Beiträge zur biologischen Aktivität einer neuen Verbindungsklasse. Archiv der Pharmazie. 325(9). 545–550. 3 indexed citations
16.
Eger, Kurt, et al.. (1992). Beiträge zur chemischen Reaktivität einer neuen Verbindungsklasse. Archiv der Pharmazie. 325(9). 551–556. 3 indexed citations
17.
Müller, Christa E., et al.. (1990). 7-Deaza-2-phenyladenines: structure-activity relationships of potent A1 selective adenosine receptor antagonists. Journal of Medicinal Chemistry. 33(10). 2822–2828. 30 indexed citations
18.
Klumpp, Susanne, et al.. (1989). Pyrrolo[2,3-d]pyrimidines as inhibitors of cAMP-phosphodiesterase. Biochemical Pharmacology. 38(6). 949–953. 8 indexed citations
19.
Daly, John W., William L. Padgett, & Kurt Eger. (1988). 7-Deaza-9-phenyladenines. Biochemical Pharmacology. 37(19). 3749–3753. 11 indexed citations
20.
Steinhilber, Dieter, Karl‐Heinz Schmidt, Kurt Eger, & Hermann J. Roth. (1986). New Class of 5-Lipoxygenase Inhibitors: Correlation Between Inhibition of LTB4 Production and Chemiluminescence of Human Polymorphonuclear Granulocytes. Pharmaceutical Research. 3(5). 271–277. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kunitomo Adachi Breakdown of academic impact, for papers by Masafumi Arita Breakdown of academic impact, for papers by Giulia Menozzi Breakdown of academic impact, for papers by Laurent Schio Breakdown of academic impact, for papers by John J. Parlow Breakdown of academic impact, for papers by Francesco Bondavalli Breakdown of academic impact, for papers by Angelo Ranise Breakdown of academic impact, for papers by William C. Ripka Breakdown of academic impact, for papers by Steven E. Hall Breakdown of academic impact, for papers by Mark E. Schnute
Rankless by CCL
2026